Meanwhile, a prophylactic vaccine for Middle East Respiratory Syndrome (MERS) is commencing phase 1 studies, a Human Papillomavirus (HPV) therapeutic ... company’s viral vector platform are ...

At its meeting on Tuesday, the CDC's Advisory Committee on Immunization Practices (ACIP) considered whether the U.S. should ...

If HPV is left untreated, it can cause cervical and head and neck cancers. Earlier years, the vaccine targeted four strains ...

United States-based global pharmaceutical company MSD said on Monday that China's National Medical Products Administration has approved the use of multiple new indications of Gardasil®9, its ...

In the first meeting of the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) ...

The incidence of Human Papillomavirus (HPV)–associated oropharyngeal cancers—tumors of the back of the mouth and throat—is ...

Despite the world possessing effective vaccines against HPV, rates of immunisation are actually falling in lower- and middle-income countries. Ben Hargreaves asks why this is happening ...

Vaccines that protect against the types of human papillomavirus (HPV) most commonly associated with squamous cell cervical carcinoma are nearing approval in the U.S. But how long will these ...

Every two minutes, a woman’s life is claimed by cervical cancer—a largely preventable disease—yet, the human papillomavirus (HPV) vaccine could save up to 560,000 lives every year. Cervical cancer is ...

Eduardo Franco has served as an occasional paid consultant to pharmaceutical and biotechnology companies involved with HPV vaccines (GSK, Merck), HPV diagnostics (Digene Corp., Roche, Gen-Probe ...